Paid Clinical Trials in District of Columbia

District of Columbia has 838 paid clinical trials enrolling now across cities including Washington D.C., Georgetown and Multiple Locations. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

756 clinical trials

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

for Locally Advanced Solid Tumor

Sites in Washington D.C. +16 more locations

Sponsor: Nuvalent Inc.

Sex: All·Age: 18+

Code: NCT06521554·Phase 1·Recruiting·Listed Jul 2024

Apply to this trial

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

for Myasthaenia Gravis

Sites in Washington D.C. +22 more locations

Sponsor: Cartesian Therapeutics

Sex: All·Age: 18+

Code: NCT06799247·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for Non Small Cell Lung Cancer

Sites in Washington D.C. +23 more locations

Sponsor: SystImmune Inc.

Sex: All·Age: 18+

Code: NCT05983432·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Terumo Aortic Global Endovascular Registry

for Abdominal Aortic Aneurysm

Sites in Washington D.C. +16 more locations

Sponsor: Vascutek Ltd.

Sex: All·Age: 18+

Code: NCT04246463·Recruiting·Listed Jan 2020

Apply to this trial

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

for Refractory Ewing Sarcoma

Drug: Lurbinectedin

Sites in Washington D.C. +13 more locations

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 2 - 30

Code: NCT05734066·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

CoMind Early Feasibility Study

for Intracranial Pressure

Sites in Washington D.C. +9 more locations

Sponsor: CoMind Technologies Limited

Sex: All·Age: 18+

Code: NCT06368648·Recruiting·Listed Apr 2024

Apply to this trial

Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries

for Pressure Ulcers Stage II

Sites in Washington D.C. +12 more locations

Sponsor: ULURU Inc.

Sex: All·Age: 18 - 85·Accepts healthy volunteers

Code: NCT05496296·Recruiting·Listed Aug 2022

Apply to this trial

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for Head and Neck Carcinoma

Sites in Washington D.C. +13 more locations

Sponsor: VM Oncology, LLC

Sex: All·Age: 18 - 80

Code: NCT03556228·Phase 1, Phase 2·Recruiting·Listed Jun 2018

Apply to this trial

Blue Light Cystoscopy With Cysview® Registry

for Bladder Cancer

Sites in Washington D.C. +20 more locations

Sponsor: Photocure

Sex: All·Age: 18+

Code: NCT02660645·Recruiting·Listed Jan 2016

Apply to this trial

Serranator POINT FORCE Registry

for Peripheral Artery Disease (PAD)

Sites in Washington D.C. +17 more locations

Sponsor: Cagent Vascular LLC

Sex: All·Age: 18+

Code: NCT06687590·Recruiting·Listed Nov 2024

Apply to this trial

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for Locally Advanced Solid Tumor

Sites in Washington D.C. +18 more locations

Sponsor: Nuvalent Inc.

Sex: All·Age: 12+

Code: NCT05118789·Phase 1, Phase 2·Recruiting·Listed Nov 2021

Apply to this trial

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

for Solid Tumors

Sites in Washington D.C. +16 more locations

Sponsor: ORIC Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05315700·Phase 1, Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

for Hypochondroplasia

Sites in Washington D.C. +15 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: Up to 15

Code: NCT06212947·Recruiting·Listed Jan 2024

Apply to this trial

A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

for Low-grade Glioma

Sites in Washington D.C. +11 more locations

Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All·Age: 6 Months - 25

Code: NCT04775485·Phase 2·Recruiting·Listed Mar 2021

Apply to this trial

CtDNA Based MRD Testing for NAC Monitoring in TNBC

for TNBC - Triple-Negative Breast Cancer

Sites in Washington D.C. +13 more locations

Sponsor: Personalis Inc.

Sex: Female·Age: 18+

Code: NCT06230185·Recruiting·Listed Jan 2024

Apply to this trial

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

for Intestinal Failure Associated Liver Disease

Sites in Washington D.C. +12 more locations

Sponsor: NorthSea Therapeutics B.V.

Sex: All·Age: 16+

Code: NCT05919680·Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment

for Ischemic Stroke

Sites in Washington D.C. +13 more locations

Sponsor: BrainQ Technologies Ltd.

Sex: All·Age: 22 - 80

Code: NCT06386874·Recruiting·Listed Apr 2024

Apply to this trial

Diagnosis of Abdominal Pain Using RNA Levels: The NATURAL Study

for Intra Abdominal Infections

1 location in Washington D.C.

Sponsor: True Bearing Diagnostics, Inc.

Sex: All·Age: 7+·Accepts healthy volunteers

Code: NCT07579312·Recruiting·Listed May 2026

Apply to this trial

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

for Venous Embolism of Lower Extremities (Diagnosis)

Sites in Washington D.C. +2 more locations

Sponsor: Medtronic Endovascular

Sex: All·Age: 22+

Code: NCT07335341·Recruiting·Listed Jan 2026

Apply to this trial

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

for Coronary Disease

Sites in Washington D.C. +1 more location

Sponsor: Teleflex

Sex: All·Age: 18 - 80

Code: NCT07258290·Recruiting·Listed Dec 2025

Apply to this trial

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

for Duchene Muscular Dystrophy

Drug: Givinostat

Sites in Washington D.C. +8 more locations

Sponsor: ITF Therapeutics LLC

Sex: All·Age: 6+

Code: NCT07127978·Recruiting·Listed Aug 2025

Apply to this trial

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

for Childhood-onset Systemic Lupus Erythematous

Sites in Washington D.C. +2 more locations

Sponsor: Cartesian Therapeutics

Sex: All·Age: 12+

Code: NCT07089121·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

for Chondral Defect

Sites in Washington D.C. +6 more locations

Sponsor: Vericel Corporation

Sex: All·Age: 17 - 65

Code: NCT06915233·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

for Heterozygous Familial Hypercholesterolemia (HeFH)

Drug: Enlicitide Decanoate

Sites in Washington D.C. +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 6 - 17

Code: NCT07058077·Phase 2, Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

for Castration-Resistant Prostatic Cancer

Sites in Washington D.C. +8 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06863272·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

for Chronic Graft Versus Host Disease

Sites in Washington D.C. +4 more locations

Sponsor: Sanofi

Sex: All·Age: 1 - 18

Code: NCT07116031·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

for Hemorrhage

Sites in Washington D.C. +8 more locations

Sponsor: Corza Medical GmbH

Sex: All·Age: 1 Month+

Code: NCT06664775·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

for Familial Hypercholesterolemia - Homozygous

Drug: Inclisiran

Sites in Washington D.C. +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 2 - 11

Code: NCT06597006·Phase 3·Recruiting·Listed Sep 2024

Apply to this trial

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

for Endometrial Cancer

Sites in Washington D.C. +9 more locations

Sponsor: BioNTech SE

Sex: Female·Age: 18+

Code: NCT06340568·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Mucopolysaccharidosis VII Disease Monitoring Program

for Mucopolysaccharidosis VII

Sites in Washington D.C. +5 more locations

Sponsor: Ultragenyx Pharmaceutical Inc

Sex: All·Age: All ages

Code: NCT03604835·Recruiting·Listed Jul 2018

Apply to this trial

Prospective Clinical Assessment Study in Children With Hypochondroplasia

for Hypochondroplasia

Sites in Washington D.C. +7 more locations

Sponsor: QED Therapeutics, a BridgeBio company

Sex: All·Age: 30 Months - 16

Code: NCT06410976·Recruiting·Listed May 2024

Apply to this trial

A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects

for Benign Centrally-Located Intracranial Tumors

Sites in Washington D.C. +2 more locations

Sponsor: InSightec

Sex: All·Age: 5 - 22

Code: NCT03028246·Recruiting·Listed Jan 2017

Apply to this trial

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Washington D.C. +6 more locations

Sponsor: Vaxiion Therapeutics

Sex: All·Age: 18+

Code: NCT05901285·Phase 1·Recruiting·Listed Jun 2023

Apply to this trial

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

for Neuromyelitis Optica Spectrum Disorder

Sites in Washington D.C. +5 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05966467·Recruiting·Listed Jul 2023

Apply to this trial

Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

for Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Sites in Washington D.C. +3 more locations

Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company

Sex: All·Age: 0 - 17

Code: NCT07080385·Phase 2, Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

for End Stage Renal Disease

Sites in Washington D.C. +6 more locations

Sponsor: Merit Medical Systems, Inc.

Sex: All·Age: 18+

Code: NCT06422871·Recruiting·Listed May 2024

Apply to this trial

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

for Solid Tumors

Sites in Washington D.C. +8 more locations

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT07123103·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

for Congenital Antithrombin Deficiency

Sites in Washington D.C. +4 more locations

Sponsor: Octapharma

Sex: All·Age: 12 - 80

Code: NCT04918173·Phase 3·Recruiting·Listed Jun 2021

Apply to this trial

Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy

for Allergic Reactions

Sites in Washington D.C. +5 more locations

Sponsor: ARS Pharmaceuticals, Inc.

Sex: All·Age: 4+

Code: NCT06834165·Phase 4·Recruiting·Listed Feb 2025

Apply to this trial

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

for Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors

Drug: Dabrafenib

Sites in Washington D.C. +7 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 1 - 100

Code: NCT05868629·Recruiting·Listed May 2023

Apply to this trial